Loading...
•
Jun 30, 2025
Insperity Q2 2025 Earnings Report
Insperity reported a Q2 2025 net loss driven by rising healthcare costs, despite growth in employees paid and revenues.
Key Takeaways
Insperity experienced a challenging Q2 2025, reporting a net loss of $5 million despite 3% revenue growth to $1.658 billion. The company saw a 1% increase in average worksite employees paid and adjusted EPS of $0.26. Rising healthcare costs pressured margins, leading to a 14% drop in gross profit.
Revenue increased 3% year-over-year to $1.658 billion.
Reported net loss of $5 million and EPS of $(0.14), with adjusted EPS at $0.26.
Gross profit dropped 14% due to elevated healthcare costs.
Average worksite employees paid rose 1% to 309,115.
Forward Guidance
Insperity expects continued growth in worksite employees paid and is actively managing costs with strategic pricing and benefit plan changes to counter healthcare cost pressures.
Positive Outlook
- Expected Q3 average WSEEs paid to rise to 312,200–315,300.
- Adjusted EPS guidance for Q3 set between $0.06 and $0.49.
- Adjusted EBITDA projected between $170M and $205M for FY25.
- Ongoing investment in Workday partnership to enhance offerings.
- Cost control measures and pricing strategies being implemented.
Challenges Ahead
- Q2 reported net loss and lowered full-year guidance.
- Continued pressure from elevated healthcare and pharmacy claims.
- Gross profit down 14% YoY, weighing on profitability.
- Operating income turned negative in the quarter.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...